Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04774913 · ClinicalTrials.gov registry record · NA

Invest-CTO PCI Trial

A NA study of Quality of Life and Angina Pectoris, sponsored by Haukeland University Hospital.

Active
Registry status
NA
Development phase
200
Enrollment target
5
Study locations

NCT04774913 is a NA study of Quality of Life and Angina Pectoris that is active but no longer recruiting, run by Haukeland University Hospital. The registered enrollment target is 200 participants, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04774913, a NA study of Quality of Life and Angina Pectoris, is active but no longer recruiting, sponsored by Haukeland University Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
5
Study locations

Study Summary

Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts. It has never been investigated whether a planned investment procedure, with an intention that both the initial and staged completion PCI are of shorter duration, could improve safety and efficacy. The investigators hypothesize that 1. A planned investment procedure in the treatment of CTOs will be associated with improved patient safety 2. A planned investment procedure will be associated with improved cumulative procedure success rates 3. A planned two stage procedure will be associated with improved patient experience

Interventions

  • PROCEDURE Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)

Study Locations (5)

Other

  • Bristol Health - Bristol
  • St George´s Hospital - London

New York

  • Columbia University Medical Center/ NewYork Presbyterian Hospital - New York

Bergen

  • Haukeland University Hospital - Bergen

Glasgow

  • Golden Jubilee National Hospital - Glasgow

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-12-08
Est. Completion 2026-10
Phase NA

Sponsor

Haukeland University Hospital

1 total trials

What the Registry Record Tells You About NCT04774913

The ClinicalTrials.gov registry entry for NCT04774913 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (56% lower). The listed sponsor is Haukeland University Hospital, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Chronic total occlusion(CTO) percutaneous coronary intervention (PCI) is the first listed.

NCT04774913 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, New York, Bergen.

Frequently Asked Questions

What is clinical trial NCT04774913 about?

NCT04774913 is a clinical study titled "Invest-CTO PCI Trial". Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts. It has never been investigated whether ...

What is the current status of trial NCT04774913?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-12-08. Estimated completion is 2026-10.

What conditions does trial NCT04774913 study?

This clinical trial studies the following conditions: Quality of Life, Angina Pectoris, Chronic Total Occlusion of Coronary Artery, PROM.

What interventions are being tested in trial NCT04774913?

The interventions under investigation include: Chronic total occlusion(CTO) percutaneous coronary intervention (PCI) (PROCEDURE).

Who is sponsoring clinical trial NCT04774913?

This trial is sponsored by Haukeland University Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04774913 being conducted?

This trial has 5 study locations across New York, Bergen, Glasgow. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.